BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab

NCT04196530 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumor, Solid

Interventions

DRUG: BDB001 (EIK1001)
DRUG: Atezolizumab

Sponsor

Eikon Therapeutics

Collaborators

[object Object]